Table 1.
Characteristics of the groups of patients obtained on the base of bacteriotherapy administration.
| OB+ | OB– | ||||
|---|---|---|---|---|---|
| (N = 28) | (N = 42) | ||||
| Characteristics | Obs. | Values | Obs. | Values | p-value |
| Age* (year) | 28 | 59 ± 14.4 | 42 | 60.5 ± 14.2 | 0.66 |
| Gender male | 28 | 17 (60.7) | 42 | 24 (57.1) | 0.77 |
| BMI* (kg/m2) | 27 | 24.7 ± 3.4 | 42 | 23.4 ± 3.5 | 0.13 |
| ALT*(IU per liter) | 27 | 22.7 ± 10.5 | 42 | 30.5 ± 22.2 | 0.16 |
| AST*(IU per liter) | 27 | 37 ± 33.5 | 42 | 40.5 ± 33 | 0.56 |
| Hb (g/dL) | 27 | 13 (12–14) | 42 | 13 (12–14) | 0.58 |
| Charlson index | 28 | 2 (1–3) | 41 | 2 (1–3) | 0.64 |
| Symptoms | |||||
| Fever | 28 | 27 (96.4) | 42 | 39 (92.9) | 0.53 |
| Cough | 28 | 22 (78.6) | 42 | 32 (76.2) | 0.82 |
| Dyspnea | 28 | 20 (71.4) | 42 | 24 (57.1) | 0.23 |
| Asthenia | 28 | 6 (21.4) | 42 | 9 (21.4) | 1.0 |
| Headache | 28 | 3 (10.7) | 42 | 8 (19.0) | 0.35 |
| Myalgia | 28 | 2 (7.1) | 42 | 2 (4.8) | 0.67 |
| Diarrhea | 28 | 14 (50.0) | 42 | 19 (45.2) | 0.70 |
| Respiratory parameters | |||||
| FiO2 (%) | 27 | 31 (21–43) | 39 | 21 (21–35) | 0.17 |
| SO2 (%) | 24 | 99 (97–99) | 36 | 99 (97–100) | 0.89 |
| pH | 26 | 7.5 (7.4–7.5) | 35 | 7.5 (7.4–7.5) | 0.71 |
| (mmol/L) | 26 | 25.47 ± 3.37 | 33 | 25.58 ± 2.74 | 0.89 |
| Lactic acid* (mmol/L) | 26 | 0.9 ± 0.4 | 34 | 0.9 ± 0.3 | 0.74 |
| pO2 (mmHg) | 27 | 89 (76–103) | 39 | 86 (77–97) | 0.73 |
| pCO2 (mmHg) | 26 | 36 (32–39) | 36 | 36 (34–39) | 0.40 |
| Oxygen support | |||||
| Venturi mask | 28 | 25 (89.3) | 42 | 38 (90.5) | 0.87 |
| CPAP | 28 | 3 (10.7) | 42 | 3 (7.1) | 0.60 |
The p-values are relative to the chi-square test and Mann–Whitney and when less of 0.05 these comparisons showed no significant differences. Obs., number of available observations for each group.
*
data log10-transformed. OB– (oral bacteriotherapy not administered group), OB+ (oral bacteriotherapy administered group).